Down 80% From Its High, Is Novavax Stock a Smart Buy Now?
This beaten-down vaccine stock appears to be dirt cheap right now.
Stay updated with breaking news from Use Authorization. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
This beaten-down vaccine stock appears to be dirt cheap right now.
ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero
"The data right now really support vaccine and boosters in particular to maintain immunity."
The Centers for Disease Control and Prevention contracted with laboratories to sequence the SARS-CoV-2 genome from positive samples across the United States to enable public health officials to investigate the impact of variants on disease severity as well as the effectiveness of vaccines and treatment. Herein we present the initial results correlating RT-PCR quality control metrics with sample collection and sequencing methods from full SARS-CoV-2 viral genomic sequencing of 24,441 positive patient samples between April and June 2021. RT-PCR confirmed (N Gene Ct value < 30)...